Have noted that the founder of Chinese Pioneer Pharma Holdings (Paul Xinzhou Li) was a director of Paragon from January 2021 until September 2021, probably being part of the time when they were invested in Paragon Care. They must have sold out at a considerable loss considering their entry price, and when they sold.
Quite intriguing that they have once again made a substantial investment in Paragon only a few years after selling out.
Ann: Becoming a substantial holder, page-10
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.005(1.10%) |
Mkt cap ! $761.4M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 46.5¢ | 45.0¢ | $170.0K | 373.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30000 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 8468 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PGC (ASX) Chart |